Somatic death Flashcards
Primary changes during somatic death: failure of circulatory, respiratory, and central nervous systems
Primary changes during somatic death (CRC)
Secondary changes after somatic death: Algor mortis, Rigor mortis, Livor mortis, Postmortem clotting, Dessication, Putrefaction, Autolysis
Secondary changes after somatic death (ARLP DPA)
Postmortem cooling at a rate of ~7°F/hour
Algor mortis
Stiffening of muscles postmortem, starts in the neck and head (2-3 hrs), persists for 3-4 days
Rigor mortis
Purplish discoloration of the body due to blood pooling; does not blanch after 10-12 hours
Livor mortis
Difference between postmortem lividity and ecchymosis: lividity disappears under pressure, ecchymosis does not
Postmortem lividity vs. Ecchymosis
Clot formed after death, RBCs settle from plasma, chicken fat present, assumes vessel shape, rubbery consistency
Postmortem clot
Clot formed before death, not detachable from vessels, no chicken fat, seldom assumes vessel shape, granular and friable
Antemortem clot
Drying and wrinkling of the anterior chamber of the eye postmortem
Dessication
Invasion of tissues by intestinal microorganisms postmortem
Putrefaction
Self-digestion of cells due to lysosomal enzyme release; lysosomes are known as the ‘suicide sac’ of the cell
Autolysis
Rotting or decomposition of the body by bacterial action
Putrefaction
Changes seen in putrefaction: Greenish-blue discoloration due to iron sulfide, muscle softening (autodigestion), corneal retraction, loss of rigor mortis, skin peeling, swelling of face
Putrefaction changes
Liberation of hydrolytic enzymes leading to self-digestion of cells, enhanced by putrefactive bacteria; no inflammatory response postmortem
Autolysis
Postmortem clot with settling and separation of RBCs from the fluid phase; appearance: Chicken fat (cleared area), Currant jelly (sediment of RBC); assumes blood vessel shape; rubbery consistency
Postmortem clot
Ante-mortem clot with tangled fibrin, irregular pattern; does not resemble blood vessels; consistency is granular, not rubbery
Ante-mortem clot
Drying and wrinkling of the cornea and anterior chamber postmortem
Dessication
1st to describe the 4 signs of inflammation
Cornelius Celsus
Redness due to increased blood flow to injury
Rubor (Redness)
Heat due to increased blood flow
Calor (Heat)
Swelling caused by capillary permeability and fluid extravasation
Tumor (Swelling)
Pain due to pressure on sensory nerves
Dolor (Pain)
Loss of function caused by destruction of functional units
Functio laesa (Loss of function)
Vascular and exudative response involving PMNs transitioning to microphages in tissues
Acute inflammation
Intermediate stage between acute and chronic inflammation
Subchronic inflammation
Vascular and fibroblastic response involving monocytes transitioning to macrophages in tissues
Chronic inflammation
Continuous abnormal proliferation of cells without control or purpose, e.g., leukemia
Neoplasia/Tumor
Chronic inflammation characterized by granuloma formation; focal aggregation of activated macrophages transformed into epithelial-like cells with pink cytoplasm, surrounded by lymphocytes and plasma cells
Granulomatous inflammation
Examples include syphilis (gummas), TB, leprosy, schistosomiasis, and Bartonella henselae
Conditions with granulomas
Resolution of inflammation with no destruction of normal tissue, neutralization of the offending agent, and clearance of mediators and inflammatory cells
Simple resolution
Replacement of lost or necrotic tissue with new tissue that is structurally and functionally similar to those destroyed
Regeneration
Grading system for tumor differentiation and treatment approach based on the percentage of differentiated and undifferentiated cells
Broder’s Classification
75-100% differentiated cells, 0-25% undifferentiated cells; Treatment: Surgery
Grade I
50-75% differentiated cells, 25-50% undifferentiated cells; Treatment: Surgery or Radiation
Grade II
25-50% differentiated cells, 50-75% undifferentiated cells; Treatment: Radiation
Grade III
0-25% differentiated cells, 75-100% undifferentiated cells; Treatment: Radiation
Grade IV